Please assess the completion status of the following clinical trial:

Trial Title: Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with chronic asthma who actively smoke at least 0.5 to no more than 2 packs of cigarettes a day~Exclusion Criteria:~* Participant cannot have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or emphysema.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Arm 1: Montelukast
- 2 (Type: ACTIVE_COMPARATOR): Arm 2: Fluticasone
- 3 (Type: PLACEBO_COMPARATOR): Arm 3: Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).